Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,151
Recruiting: 2,258
Ph III recruiting: 267
Growth YoY: +13.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 151–200 of 2,779 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05550415	The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer	recruiting	Phase 2	26	Universitas IndonesiaOTHER	1	Sep 21, 2026	clinicaltrials
NCT05578326	Study of Trilaciclib and Lurbinectidin	recruiting	Phase 2	30	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Sep 21, 2026	clinicaltrials